Europe
The lessons learned from the global pandemic are expected to translate to existing and emerging therapeutic areas - particularly oncology; more efficient regulatory-industry relationships; mRNA is a word we will continue to hear a lot about; and home health care is here to stay.
The new year began with a fairly low level of clinical trial news. Here’s a look.
News, much of it good, keeps coming in about the efficacy of the various COVID-19 vaccines. Here’s a look.
Merck KGaA buys Amptec for mRNA tech and Chimerix acquires Oncoceutics for cancer pipeline.
BioSpace spoke to executives from four companies about their expectations for the conference and the coming year.
Here’s a run-down of some of the most recent collaboration announcements this week.
Frank Nestle, Sanofi’s chief scientific officer and Global Head of Research, and Dietmar Berger, Sanofi’s chief medical officer and Global Head of Development, provided an overview of the company’s clinical activities and highlighted some assets that will be key revenue drives for the company.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
DBV announced official restructuring plan for keeping the company afloat.
The recalibration will also have workforce implications, including an overall workforce reduction of approximately 20% during Q1, 2021.
PRESS RELEASES